News | Renovion

2 min

Renovion Provides Regulatory Update and Initiation of Clinical Program in Non-CF Bronchiectasis

Chapel Hill, NC, April 7, 2022 – Renovion, Inc., a clinical-stage pharmaceutical company focused on developing treatments for rare,...

Renovion

3 min

Marty Zamora, MD, joins Renovion, Inc. as Chief Medical Officer

CHAPEL HILL, North Carolina, April 12, 2022-- Renovion today announced that Dr. Martin “Marty” Zamora, MD, has joined Renovion as Chief...

Renovion

5 min

A breathe-easier breakthrough

Renovion, a UNC-affiliated startup, advances a breakthrough therapy to restore lung health and quality of life in patients with diseases...

Renovion

3 min

Exploristics signs collaboration agreement with Renovion, using the cloud-based simulation platform

Exploristics is pleased to announce today a collaboration with Renovion using Exploristics’ innovative study simulation software platform...

Renovion

3 min

Renovion and the COPD Foundation Launch COPD and Bronchiectasis Development Partnership to Address

Chapel Hill, NC and Miami, FL - Renovion and the COPD Foundation have announced the creation of a new partnership to accelerate the...

Renovion

2 min

Renovion Announces Addition of Rich Mattingly to Board of Directors

Renovion, Inc., a biopharmaceutical company on a mission to transform the treatment of chronic inflammatory lung diseases, announced the...

Renovion

2 min

Publication of Research Demonstrating the Impact of ARINA-1 on Mucus Transport in Cystic Fibrosis

CHAPEL HILL, N.C., July 9, 2020 -- Renovion, Inc., a biopharmaceutical company on a mission to transform the lives of patients with...

Renovion

3 min

Completion of $8.1 Million Financing Round Enabling Clinical Programs in Chronic Lung Diseases

Poised for pivotal lung transplant trial in U.S. CHAPEL HILL, N.C., June 18, 2020 /Businesswire/ -- Renovion, Inc., a biopharmaceutical...

Renovion

2 min

Dr. Robert Ryan joins Renovion, Inc. Board of Directors

CHAPEL HILL, N.C., March 1, 2018 -- Renovion, Inc., a privately-held biopharmaceutical company developing novel therapeutics for...

Renovion

2 min

Renovion Elects Derek Winstanly as Chairman of Board of Directors

December 20, 2017 09:00 AM Eastern Standard Time DURHAM, N.C.--(BUSINESS WIRE)--Renovion, Inc. ("Renovion"), an early stage drug...

Renovion

2 min

Renovion, Inc. Receives Orphan Designation for Arina-1 for the Treatment of Lung Dysfunction followi

Renovion, Inc. announced today that the FDA Office of Orphan Products has granted Orphan Designation in the US to the Company's nebulized...

Renovion

2 min

Chapel Hill startups represent in D.C.

Two Chapel Hill-based startups — EpiCypher and Renovion — attended the first University Startups Demo Day in Washington, D.C. CHAPEL...

Renovion

3 min

‘Spirit of innovation’

CHAPEL HILL, N.C., September 19, 2016. Of the more than 800 startups created at universities across the country this year, only 35 have...

Renovion

2 min

Entrepreneur with GSK roots targets lung transplant survival rates with UNC technology

In a tiny lab in Chapel Hill, a 3-year-old startup with UNC-Chapel Hill technology is trying to help lung transplant patients defy the...

Renovion

2 min

Renovion Receives Patent Allowance for Novel Therapy

- Patent claims set foundation for commercialization - Board and management team in place to execute pre-clinical plan CHAPEL HILL, N.C.,...